Perspective Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

1Department of Medicine, Divisions of Dermatology and Oncology, Duke University Medical Center, Durham, NC; 2Department of Dermatology, Johns Hopkins University, Baltimore, MD; 3Department of Dermatological Sciences, University of Florence, Florence, Italy; 4Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; 5Department of Dermatology, Stanford University Medical Center, Stanford, CA; 6Department of Dermatology, University of Vienna, Vienna, Austria; 7Department of Dermatology, University of California at San Francisco; 8Department of Dermatology, University of Texas at Houston; 9Department of Dermatology, University of Barcelona, Barcelona, Spain; 10Department of Dermatology, University of Wisconsin, Madison; 11Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; 12Department of Dermatology and Venereal Diseases, Helsinki University Hospital, Helsinki, Finland; 13Department of Dermatology, Yale University, New Haven, CT; 14Department of Dermatology, Mayo Clinic, Rochester, MN; 15Department of Dermatology, University of Turin, Turin, Italy; 16Department of Dermatology, Charité, Humboldt University, Berlin, Germany; 17Department of Immuno-Dermatology, Hospital Avicenne–University of Paris XIII, Paris, France; 18St John’s Institute of Dermatology, Skin Tumour Unit, St Thomas’ Hospital, London, United Kingdom